About Raptim Research
Raptim Research is a company based in Mumbai (India) founded in 2005. It operates as a B2B. Raptim Research offers products and services including Clinical Trials, BA/BE Studies, In-Vitro Studies, Special Studies, and Bioanalytical Services. Raptim Research operates in a competitive market with competitors including Emmes, Syneos Health, Veristat, ClinChoice and Medelis WCCT Global, among others.
- Headquarter Mumbai, India
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Raptim Research Pvt. Ltd
- Date of Incorporation 17 Jun, 2002
- Jurisdiction Navi Mumbai, Maharashtra, India
-
Annual Revenue
$21.11 M (USD)5.05as on Mar 31, 2023
-
Net Profit
$3.29 M (USD)-19.02as on Mar 31, 2023
-
EBITDA
$5.73 M (USD)-10.74as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Raptim Research
Raptim Research offers a comprehensive portfolio of products and services, including Clinical Trials, BA/BE Studies, In-Vitro Studies, Special Studies, and Bioanalytical Services.
Management of early and late-phase trials for drug development
Pharmacokinetics and bioavailability studies for new drugs
In-vitro release and permeability tests for product evaluation
Specialized tests like skin irritation and glucose clamp studies
Method development and validation for pharmaceutical analysis
People of Raptim Research
Unlock access to complete
Funding Insights of Raptim Research
Detailed funding history for Raptim Research
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Raptim Research
Investment portfolio details for Raptim Research
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Raptim Research
Detailed financials for Raptim Research
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Raptim Research Comparisons
Peer comparison for Raptim Research
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Raptim Research
Raptim Research operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Emmes, Syneos Health, Veristat, ClinChoice and Medelis WCCT Global, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Outsourced contract research organization services are provided to clients.
|
|
| Locked | Locked | Locked |
CRO clinical development services are provided by Syneos Health.
|
|
| Locked | Locked | Locked |
Clinical trials and regulatory submissions are supported as a CRO.
|
|
| Locked | Locked | Locked |
CRO focused on data management, regulatory affairs and consulting services
|
|
| Locked | Locked | Locked |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| Locked | Locked | Locked |
Therapies for cancer and inflammatory diseases are developed.
|
Detailed competitors of Raptim Research
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Raptim Research
Complete news archive for Raptim Research
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Raptim Research
Raptim Research was founded in 2005.
Raptim Research is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Annual revenue of Raptim Research is $21.11M as on Mar 31, 2023.
Raptim Research is a full-service Contract Research Organization specializing in early and late-phase clinical research. They offer services like bioequivalence studies, in-vitro testing, and clinical trials across various therapeutic areas. Operating from locations in India and the USA, they serve biopharmaceutical, medical device, and consumer healthcare clients. The company emphasizes regulatory compliance, data integrity, and global support to accelerate research and development.
Raptim Research's top competitors include Emmes, Syneos Health and ClinChoice.
Raptim Research offers Clinical Trials, BA/BE Studies, In-Vitro Studies, Special Studies, and Bioanalytical Services.